Search results for

NPR's Mary Louise Kelly speaks with Joel Wit, a senior fellow at the US-Korea Institute at Johns Hopkins, who was involved in negotiations with North Korea since the Clinton Administration, and has continued to talk with North Korean officials as recently as last year.

Scientists are trying to develop drugs to counteract an "undruggable" genetic variant that's responsible for about 30 percent of all cancer cases. It's high risk — high reward research.

NPR's Rachel Martin talks with Collin Binkley of The Associated Press about an AP investigation into millions of dollars the NRA gives to schools.

California could be the first state to create a statewide, online community college system targeting 2.5 million workers who need — but don't have — a college degree.

Rachel Martin talks to Secretary of Commerce Wilbur Ross on President Trump's reasons behind tariffs on imports of steel and aluminum. The tariffs have been criticized as too harsh.

Because of layers of material that can be difficult to separate, many containers for juices and broths have traditionally been destined for landfills. But recycling them is getting easier.

Rachel Martin talks to Republican Sen. Cory Gardner of Colorado about his reaction to President Trump agreeing to meet North Korea's leader. The invitation was facilitated by South Korean diplomats.

Wilbur Ross, a leading advocate for the steel and aluminum tariffs the president announced this week, told NPR's Morning Edition the tariffs' impact isn't "much of a roar."

Indian drugmakers like to come up with combos — two meds in one pill. They can make more money that way. And they say it's easier for patients to take one pill than two. But is there a downside?

You probably didn't know that emperor penguins are reasonably good at framing a video shot. At a research station in Antarctica, the curious animals provided a bird's-eye view.